Pricing Log in Create free account
Saturday 17 October 2026 Export MDT’s income statement to Excel — free account

Medtronic PLC

MDT Healthcare Medical Devices

Medtronic PLC’s revenue for fiscal 2026 (year ended April 2026) was $36.4 billion, up 8.43% from fiscal 2025. In the quarter to July 2026, revenue grew 13.7%, EPS grew 42.0%, free cash flow grew 120.9% and total debt fell 1.59%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for three, operating cash flow growth for three.

94.75 0.70 −0.73%
Market cap
$122.1B
P/E
23.2×
Fwd P/E
18.7×
Dividend yield
3.02%
F-score
7/9
Altman Z
2.73
Beneish M
−2.58
Dividend safety
61/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Medtronic PLC (MDT) Price to free cash flow

Alert me on Price to free cash flow

As of 16 October 2026, Medtronic PLC (MDT) trades at a price to free cash flow of 19.8×. Over the past ten years it has ranged from 12.5× (January 2015) to 38.2× (April 2021); the current reading is higher than 17% of that period. That is below the Medical Devices industry median of 23.7× and in line with the Healthcare sector median of 20.2×.

Price to free cash flow, daily

Embed this chart

Annual newest first

Period Price to free cash flow Change
FY2026 19.1× (8.98%)
FY2025 21.0× 2.58%
FY2024 20.5× (22.19%)
FY2023 26.3× 13.68%
FY2022 23.2× (35.74%)
FY2021 36.0× 65.80%
FY2020 21.7× 6.78%
FY2019 20.4× (32.28%)
FY2018 30.1× 46.48%
FY2017 20.5× (23.45%)

Quarterly newest first

Period Price to free cash flow Change
Jul 2026 17.8× (6.83%)
Apr 2026 19.1× (21.45%)
Jan 2026 24.4× 9.02%
Oct 2025 22.3× 2.41%
43 more quarters

Against its own ten years

Low 12.5× High 38.2×
Ten-year median 22.9×
Current reading's percentile 17

Price to free cash flow against peers

Company Price to free cash flow
PHG Koninklijke Philips N.V. compare 13.3×
BSX Boston Scientific Corporation compare 18.0×
MDT Medtronic PLC 19.8×
GEHC GE HealthCare Technologies Inc. compare 20.0×
STE STERIS plc compare 23.2×
ABT Abbott Laboratories compare 23.3×
DXCM DexCom, Inc. compare 23.4×
SYK Stryker Corporation compare 24.0×
EW Edwards Lifesciences Corporation compare 35.6×
Medical Devices industry median 23.7×
Healthcare sector median 20.2×
Market median 14.2×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on MDT